EntryPoint Capital’s Guardian Pharmacy Services GRDN Stock Holding History

EntryPoint Capital’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,537	Closed	-$359K	–	997
2026 Q1	$359K	Buy	9,537 +1,899	+25%	+$62K	0.11%	390
2025 Q4	$230K	Buy	+7,638	New	+$216K	0.09%	482

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

EntryPoint Capital's GRDN Position: Q2 2026 in Review

EntryPoint Capital sold out of Guardian Pharmacy Services (GRDN) in Q2 2026, closing a stake of 9,537 shares — an estimated $359K sold.

EntryPoint Capital first reported a position in GRDN in Q4 2025 and held it in 2 quarters. The position peaked at $359K in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

EntryPoint Capital reported no remaining Guardian Pharmacy Services position as of Q2 2026 after selling out during the quarter.
EntryPoint Capital sold 9,537 Guardian Pharmacy Services shares in Q2 2026, an estimated $359K.
EntryPoint Capital first reported a position in Guardian Pharmacy Services in Q4 2025 and held it in 2 quarters.
EntryPoint Capital's Guardian Pharmacy Services position peaked at $359K in Q1 2026.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.